CHS Cancer Clinical Trials
The Future of Cancer Therapy
CHS is strengthening its commitment to providing outstanding cancer care for Long Islanders by becoming a member of Roswell Park Care Network. Based in upstate New York, Roswell Park has long enjoyed a sterling reputation as one of the nation's premier cancer centers.
Now it is partnering with physicians, hospitals and supportive care teams across the state to create an expansive community-based care network dedicated to easing the burden of cancer. This network provides increased access to clinical trials—some of which are only available at Roswell Park.
Through its affiliation with Roswell Park, CHS has the opportunity to provide cancer patients with some of the newest and most innovative treatments available only through clinical trials.
Call 844-86-CANCER (844-862-2637) or submit a form for more information.
The Future of Cancer Care at Roswell Park (Video courtesy of Roswell Park Comprehensive Care Center)
Learn more about Roswell Park (Video courtesy of Roswell Park Comprehensive Care Center)
Why Clinical Trials?
A clinical trial is a type of clinical research study that tests the safety and effectiveness of new medical approaches. Some clinical trials test a drug, a medical device or a new way of doing surgery. Other trials test new ways to prevent disease, diagnose cancer or improve quality of life. Clinical trials play an essential role in the fight against cancer. They are the only scientific way to prove whether a new treatment works better than the current standard of care. (Source: Roswell Park)
Find a Clinical Trial
Current open trial:
Phase II Study of Targeting CD28 in Multiple Myeloma with Abatacept to Overcome Resistance to Chemotherapy
This Phase II trial studies how well abatacept, ixazomib citrate, and dexamethasone work in treating patients with multiple myeloma that is resistant to chemotherapy. Abatacept may block certain proteins that are present on multiple myeloma cells that have been shown to protect against chemotherapy. Drugs used in chemotherapy, such as ixazomib citrate and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving abatacept, ixazomib citrate, and dexamethasone may work better at treating patients with multiple myeloma resistant to chemotherapy.
Watch: Signs and Symptoms of Myeloma (Courtesy of Roswell Park Comprehensive Care Center)